General Atlantic
Latest statistics and disclosures from General Atlantic's latest quarterly 13F-HR filing:
- Top 5 stock holdings are Engagesmart, DLO, XP, SQSP, ALHC, and represent 68.47% of General Atlantic's stock portfolio.
- Added to shares of these 2 stocks: Karuna Therapeutics Ord (+$44M), SLRN (+$14M).
- Reduced shares in these 4 stocks: SQSP (-$167M), DNA (-$60M), YOU (-$17M), FUTU.
- Sold out of its position in DNA.
- General Atlantic was a net seller of stock by $-186M.
- General Atlantic has $6.5B in assets under management (AUM), dropping by 2.11%.
- Central Index Key (CIK): 0001017645
Tip: Access up to 7 years of quarterly data
Positions held by General Atlantic consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelPortfolio Holdings for General Atlantic
General Atlantic holds 29 positions in its portfolio as reported in the September 2023 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
---|---|---|---|---|---|---|
Engagesmart | 25.1 | $1.6B | 90M | 17.99 |
|
|
Dlocal Cl A (DLO) | 18.9 | $1.2B | 64M | 19.17 |
|
|
XP Cl A (XP) | 10.5 | $683M | 30M | 23.05 |
|
|
Squarespace Cl A (SQSP) | 7.4 | $481M | -25% | 17M | 28.97 |
|
Alignment Healthcare (ALHC) | 6.5 | $423M | 61M | 6.94 |
|
|
Alkami Technology (ALKT) | 5.3 | $341M | 19M | 18.22 |
|
|
Hireright Holdings Corporati (HRT) | 4.7 | $305M | 32M | 9.51 |
|
|
European Wax Center Cl A (EWCZ) | 3.3 | $212M | 13M | 16.20 |
|
|
Mobileye Cl A (MBLY) | 3.1 | $198M | 4.8M | 41.55 |
|
|
Karuna Therapeutics Ord | 2.6 | $167M | +35% | 987k | 169.09 |
|
Duolingo Cl A (DUOL) | 1.5 | $96M | 581k | 165.87 |
|
|
Pharvaris N V (PHVS) | 1.4 | $92M | 4.4M | 20.87 |
|
|
Akero Therapeutics (AKRO) | 1.4 | $90M | 1.8M | 50.58 |
|
|
Clear Secure Cl A (YOU) | 1.2 | $76M | -18% | 4.0M | 19.04 |
|
Hutchmed Sponsored Ads (HCM) | 1.0 | $68M | 4.0M | 16.94 |
|
|
Futu Spon Ads Cl A (FUTU) | 1.0 | $64M | 1.1M | 57.81 |
|
|
Centessa Pharmaceuticals Sponsored Ads (CNTA) | 1.0 | $63M | 9.7M | 6.47 |
|
|
Arco Platform Cl A | 0.9 | $57M | 4.1M | 13.78 |
|
|
Immunocore Ads (IMCR) | 0.8 | $49M | 950k | 51.90 |
|
|
Royalty Pharma Shs Class A (RPRX) | 0.6 | $41M | 1.5M | 27.14 |
|
|
Acelyrin (SLRN) | 0.5 | $29M | +92% | 2.9M | 10.17 |
|
Blend Labs Cl A (BLND) | 0.4 | $26M | 19M | 1.37 |
|
|
Riskified Cl A (RSKD) | 0.4 | $24M | 5.3M | 4.48 |
|
|
Third Harmonic Bio (THRD) | 0.3 | $19M | 3.0M | 6.39 |
|
|
Opendoor Technologies (OPEN) | 0.3 | $17M | 6.3M | 2.64 |
|
|
Buzzfeed Cl A (BZFD) | 0.0 | $3.0M | 7.9M | 0.38 |
|
|
Wish Cl A New (WISH) | 0.0 | $2.7M | 610k | 4.41 |
|
|
Grove Collaborative Cl A (GROV) | 0.0 | $2.5M | 936k | 2.66 |
|
|
Adagene Ads (ADAG) | 0.0 | $404k | 264k | 1.53 |
|
Past Filings by General Atlantic
SEC 13F filings are viewable for General Atlantic going back to 2010
- General Atlantic 2023 Q3 filed Nov. 14, 2023
- General Atlantic 2023 Q2 filed Aug. 11, 2023
- General Atlantic 2023 Q1 filed May 15, 2023
- General Atlantic 2022 Q4 filed Feb. 14, 2023
- General Atlantic 2022 Q3 filed Nov. 14, 2022
- General Atlantic 2022 Q2 filed Aug. 12, 2022
- General Atlantic 2022 Q1 filed May 16, 2022
- General Atlantic 2021 Q4 filed Feb. 11, 2022
- General Atlantic 2021 Q3 filed Nov. 15, 2021
- General Atlantic 2021 Q2 filed Aug. 13, 2021
- General Atlantic 2021 Q1 filed May 17, 2021
- General Atlantic 2020 Q4 filed Feb. 12, 2021
- General Atlantic 2020 Q3 filed Nov. 13, 2020
- General Atlantic 2020 Q2 filed Aug. 13, 2020
- General Atlantic 2020 Q1 filed May 14, 2020
- General Atlantic 2019 Q4 filed Feb. 13, 2020